Literature DB >> 23671030

Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Shichun Peng1, Yilong Ma, Phoebe G Spetsieris, Paul Mattis, Andrew Feigin, Vijay Dhawan, David Eidelberg.   

Abstract

To generate imaging biomarkers from disease-specific brain networks, we have implemented a general toolbox to rapidly perform scaled subprofile modeling (SSM) based on principal component analysis (PCA) on brain images of patients and normals. This SSMPCA toolbox can define spatial covariance patterns whose expression in individual subjects can discriminate patients from controls or predict behavioral measures. The technique may depend on differences in spatial normalization algorithms and brain imaging systems. We have evaluated the reproducibility of characteristic metabolic patterns generated by SSMPCA in patients with Parkinson's disease (PD). We used [(18) F]fluorodeoxyglucose PET scans from patients with PD and normal controls. Motor-related (PDRP) and cognition-related (PDCP) metabolic patterns were derived from images spatially normalized using four versions of SPM software (spm99, spm2, spm5, and spm8). Differences between these patterns and subject scores were compared across multiple independent groups of patients and control subjects. These patterns and subject scores were highly reproducible with different normalization programs in terms of disease discrimination and cognitive correlation. Subject scores were also comparable in patients with PD imaged across multiple PET scanners. Our findings confirm a very high degree of consistency among brain networks and their clinical correlates in PD using images normalized in four different SPM platforms. SSMPCA toolbox can be used reliably for generating disease-specific imaging biomarkers despite the continued evolution of image preprocessing software in the neuroimaging community. Network expressions can be quantified in individual patients independent of different physical characteristics of PET cameras.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson's disease; brain imaging; emission tomography; principal component analysis; spatial covariance analysis

Mesh:

Substances:

Year:  2013        PMID: 23671030      PMCID: PMC3778048          DOI: 10.1002/hbm.22295

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  51 in total

Review 1.  Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models.

Authors:  K M Petersson; T E Nichols; J B Poline; A P Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

2.  Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.

Authors:  Andrew Feigin; Angelo Antonini; Masafumi Fukuda; Roberta De Notaris; Riccardo Benti; Gianni Pezzoli; Marc J Mentis; James R Moeller; David Eidelberg
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.

Authors:  M Fukuda; M J Mentis; Y Ma; V Dhawan; A Antonini; A E Lang; A M Lozano; J Hammerstad; K Lyons; W C Koller; J R Moeller; D Eidelberg
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

5.  Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.

Authors:  Phoebe G Spetsieris; David Eidelberg
Journal:  Neuroimage       Date:  2010-10-20       Impact factor: 6.556

6.  Primary dystonia: is abnormal functional brain architecture linked to genotype?

Authors:  Maja Trost; Maren Carbon; Christine Edwards; Yilong Ma; Deborah Raymond; Marc J Mentis; James R Moeller; Susan B Bressman; David Eidelberg
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

7.  Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

Authors:  Chris C Tang; Kathleen L Poston; Thomas Eckert; Andrew Feigin; Steven Frucht; Mark Gudesblatt; Vijay Dhawan; Martin Lesser; Jean-Paul Vonsattel; Stanley Fahn; David Eidelberg
Journal:  Lancet Neurol       Date:  2010-01-08       Impact factor: 44.182

8.  Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.

Authors:  Maja Trost; Sherwin Su; Philip Su; Ruoh-Fang Yen; Ham-Min Tseng; Anna Barnes; Yilong Ma; David Eidelberg
Journal:  Neuroimage       Date:  2006-02-08       Impact factor: 6.556

Review 9.  Metabolic brain networks in translational neurology: concepts and applications.

Authors:  Martin Niethammer; David Eidelberg
Journal:  Ann Neurol       Date:  2012-08-31       Impact factor: 10.422

10.  Abnormal metabolic networks in atypical parkinsonism.

Authors:  Thomas Eckert; Chengke Tang; Yilong Ma; Nathaniel Brown; Tanya Lin; Steven Frucht; Andrew Feigin; David Eidelberg
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

View more
  22 in total

1.  Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.

Authors:  Yilong Ma; Tom H Johnston; Shichun Peng; Chuantao Zuo; James B Koprich; Susan H Fox; Yihui Guan; David Eidelberg; Jonathan M Brotchie
Journal:  Mov Disord       Date:  2015-08       Impact factor: 10.338

2.  Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.

Authors:  Martin Niethammer; Chris C Tang; Peter A LeWitt; Ali R Rezai; Maureen A Leehey; Steven G Ojemann; Alice W Flaherty; Emad N Eskandar; Sandra K Kostyk; Atom Sarkar; Mustafa S Siddiqui; Stephen B Tatter; Jason M Schwalb; Kathleen L Poston; Jaimie M Henderson; Roger M Kurlan; Irene H Richard; Christine V Sapan; David Eidelberg; Matthew J During; Michael G Kaplitt; Andrew Feigin
Journal:  JCI Insight       Date:  2017-04-06

3.  Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.

Authors:  Shichun Peng; Yilong Ma; Joseph Flores; Michael Cornfeldt; Branka Mitrovic; David Eidelberg; Doris J Doudet
Journal:  J Nucl Med       Date:  2016-04-07       Impact factor: 10.057

4.  Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.

Authors:  Ping Wu; Huan Yu; Shichun Peng; Yves Dauvilliers; Jian Wang; Jingjie Ge; Huiwei Zhang; David Eidelberg; Yilong Ma; Chuantao Zuo
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

5.  The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.

Authors:  Petra Tomše; Luka Jensterle; Sebastijan Rep; Marko Grmek; Katja Zaletel; David Eidelberg; Vijay Dhawan; Yilong Ma; Maja Trošt
Journal:  Phys Med       Date:  2017-02-07       Impact factor: 2.685

6.  Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.

Authors:  Jingjie Ge; Jianjun Wu; Shichun Peng; Ping Wu; Jian Wang; Huiwei Zhang; Yihui Guan; David Eidelberg; Chuantao Zuo; Yilong Ma
Journal:  Hum Brain Mapp       Date:  2018-03-13       Impact factor: 5.038

7.  Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.

Authors:  Sanne K Meles; Chris C Tang; Laura K Teune; Rudi A Dierckx; Vijay Dhawan; Paul J Mattis; Klaus L Leenders; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

8.  Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.

Authors:  Petra Tomše; Luka Jensterle; Marko Grmek; Katja Zaletel; Zvezdan Pirtošek; Vijay Dhawan; Shichun Peng; David Eidelberg; Yilong Ma; Maja Trošt
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

9.  Network modulation following sham surgery in Parkinson's disease.

Authors:  Ji Hyun Ko; Andrew Feigin; Paul J Mattis; Chris C Tang; Yilong Ma; Vijay Dhawan; Matthew J During; Michael G Kaplitt; David Eidelberg
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

10.  Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.

Authors:  Ganna Blazhenets; Lars Frings; Yilong Ma; Arnd Sörensen; David Eidelberg; Jens Wiltfang; Philipp T Meyer
Journal:  Neurology       Date:  2021-01-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.